Follow-up period | |||||||||
---|---|---|---|---|---|---|---|---|---|
 | 1 month | 3 months | 6 months | 12 months | p-value* | ||||
Original study arm | TCA (N = 7) | NaCl (N = 5) | TCA (N = 7) | NaCl (N = 5) | TCA (N = 7) | NaCl (N = 5) | TCA (N = 7) | NaCl (N = 5) | Â |
mean severity of pain (SD) | 1.33 (2.05) | 1.20 (1.65) | 1.25 (1.88) | 1.98 (1.82) | 2.55 (2.98) | 1.32 (1.41) | 2.47 (2.93) | 1.41 (1.31) | 0.67 |
mean score Dutch AIMS-2-HFF (SD) | 1.20 (0.25) | 1.30 (0.45) | 1.24 (0.29) | 1.47 (0.34) | 1.59 (1.16) | 1.82 (0.85) | 1.50 (0.99) | 2.44 (1.27) | 0.36 |
mean perceived improvement (SD) | 1.44 (0.95) | 1.38 (0.90) | 1.84 (0.37) | 1.25 (0.73) | 1.43 (0.73) | 1.01 (1.04) | 1.60 (0.73) | 1.03 (1.01) | 0.02 |